Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Kammertöns, Thomas Dr. (7) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (2) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (11) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (4) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (11) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (8) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (26) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (9) (-) Biologie maligner Lymphome (9) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (26) Translationale Onkologie solider Tumore (87) Translationale Tumorimmunologie (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (12) (-) 2004 (10) (-) 2005 (12) (-) 2006 (5) 2007 (7) 2008 (7) 2009 (5) (-) 2010 (8) 2011 (9) 2012 (8) 2013 (13) 2014 (5) 2015 (6) 2016 (5) 2017 (9) 2018 (5) 2019 (6) 2020 (4) 2021 (8) 2022 (10) 2023 (11) 2024 (2) 35 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 2004200520062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein 16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein 19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken 01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 01. Januar 2004 / Nat Immunol A cancer immunosurveillance controversy Z.H. Qin T. Blankenstein 01. Januar 2004 / Biochim Biophys Acta Gene Struct Expr Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2 B. Schories M. Janz B. Doerken K. Bommert Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 Nächste Seite Next › Letzte Seite Last »
15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
01. Januar 2004 / Biochim Biophys Acta Gene Struct Expr Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2 B. Schories M. Janz B. Doerken K. Bommert